Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 801–900 of 1,002
iPS Cell Transplantation for Traumatic Spinal Cord Injury
Goulão, M., & Lepore, A. C. (2016) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x10666150723150059 · Cited by 20
Genetic and Epigenetic Instability of Stem Cells
Rajamani, K., Li, Y.-S., Hsieh, D.-K., Lin, S., Harn, H., & Chiou, T. (2014) · Cell Transplantation · doi:10.3727/096368914x678472 · Cited by 20
Challenges in the Translation of Cardiovascular Cell Therapy
Gupta, R., & Losordo, D. W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.068304 · Cited by 20
Without a trace? PiggyBac-ing toward pluripotency
Stadtfeld, M., & Hochedlinger, K. (2009) · Nature Methods · doi:10.1038/nmeth0509-329 · Cited by 20
Self-citationDNA Repair Mechanisms in Huntington’s Disease
Jonson, I., Ougland, R., & Larsen, E. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8409-7 · Cited by 19
Nuclear reprogramming with a non-integrating human RNA virus
Driscoll, C. B., Tonne, J. M., Khatib, M. M. E., Cattaneo, R., Ikeda, Y., & Devaux, P. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0035-z · Cited by 19
Transcription factor‐mediated reprogramming: epigenetics and therapeutic potential
Firas, J., Liu, X., Lim, S. M., & Polo, J. M. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.5 · Cited by 19
Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells
Phanthong, P., Raveh-Amit, H., Li, T., Kitiyanant, Y., & Dinnyés, A. (2013) · Biogerontology · doi:10.1007/s10522-013-9455-2 · Cited by 19
Liu, J., Sümer, H., Leung, J., Upton, K. R., Dottori, M., Pébay, A., & Verma, P. J. (2011) · Cell Transplantation · doi:10.3727/096368910x514305 · Cited by 19
The role of p53 in limiting somatic cell reprogramming
Liu, Y., Hoya-Arias, R., & Nimer, S. D. (2009) · Cell Research · doi:10.1038/cr.2009.121 · Cited by 19
Hu, C., & Li, L. (2015) · Regenerative Medicine · doi:10.2217/rme.15.79 · Cited by 19
Navarro, S., Moleiro, V., Molina-Estévez, F. J., Lozano, M. L., Chinchon, R., Almarza, E., Bustamante, O. Q., Mostoslavsky, G., Maetzig, T., Galla, M., et al. (2014) · Stem Cells · doi:10.1002/stem.1586 · Cited by 19
Ji, H., Zhang, X., Oh, S., Mayhew, C. N., Ulm, A., Somineni, R. P., Ericksen, M. B., Wells, J. M., & Hershey, G. K. K. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.038 · Cited by 19
2D biointerfaces to study stem cell–ligand interactions
Zhang, X., & van Rijt, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.044 · Cited by 19
Benati, D., Leung, A., Perdigão, P. R. L., Toulis, V., van der Spuy, J., & Recchia, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315276 · Cited by 19
Strategies to Generate Induced Pluripotent Stem Cells
Hayes, M., & Zavazava, N. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-478-4_6 · Cited by 19
Rehman, A., Fatima, I., Noor, F., Qasim, M., Wang, P., jia, J., Alshabrmi, F. M., & Liao, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108661 · Cited by 19
Advances and applications of induced pluripotent stem cells
Pietronave, S., & Prat, M. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-125 · Cited by 19
Jung, L., Tropel, P., Moal, Y., Teletin, M., Jeandidier, É., Gayon, R., Himmelspach, C., Bello, F., André, C., Tosch, A., et al. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau012 · Cited by 19
Application of Epigenome‐Modifying Small Molecules in Induced Pluripotent Stem Cells
Lu, J., Kong, X., Luo, C., & Li, K. K. (2012) · Medicinal Research Reviews · doi:10.1002/med.21265 · Cited by 19
Li, N., Mu, H., Zheng, L., Li, B., Wu, C., Niu, B., Shen, Q., He, X., & Hua, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7187 · Cited by 19
Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies
Adami, R., & Bottai, D. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09910-6 · Cited by 19
Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective
Wang, H., Fang, H., Dai, J., Liu, G., & Xu, Z. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1145-3 · Cited by 19
Cell Therapy for Parkinson’s Disease: New Hope from Reprogramming Technologies
Chen, Z. (2015) · Aging and Disease · doi:10.14336/ad.2014.1201 · Cited by 19
Application of iPS in Assisted Reproductive Technology: Sperm from Somatic Cells?
Yao, L., Yu, X., Ning, H., & Liu, S. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9236-8 · Cited by 19
Transcriptional Changes in Somatic Cells Recovered From Embryonic Stem–Somatic Heterokaryons
Sümer, H., Jones, K. L., Liu, J., Rollo, B., van Boxtel, A. L., Pralong, D., & Verma, P. J. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0361 · Cited by 19
Induced pluripotent stem cells – alchemist's tale or clinical reality?
Rashid, S. T., & Vallier, L. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001596 · Cited by 18
Rovina, D., Castiglioni, E., Niro, F., Mallia, S., Pompilio, G., & Gowran, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196997 · Cited by 18
Dental applications of induced pluripotent stem cells and their derivatives
Gao, P., Liu, S., Wang, X., & Ikeya, M. (2022) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2022.03.002 · Cited by 18
Jincho, Y., Araki, R., Hoki, Y., Tamura, C., Nakamura, M., Ando, S., Kasama, Y., & Abe, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115915 · Cited by 18
Retinal Pigment Epithelium Differentiation of Stem Cells: Current Status and Challenges
Uygun, B. E., Sharma, N. S., & Yarmush, M. L. (2009) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v37.i4-5.30 · Cited by 18
Reprogramming of Human Huntington Fibroblasts Using mRNA
Arnold, A., Naaldijk, Y., Fabian, C., Loeffler‐Wirth, H., Binder, H., Nikkhah, G., Armstrong, L., & Stolzing, A. (2011) · ISRN Cell Biology · doi:10.5402/2012/124878 · Cited by 18
Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells
Sugawara, T., Nishino, K., Umezawa, A., & Akutsu, H. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt99 · Cited by 18
Stem Cell Therapy for Parkinson’s Disease
Han, F., & Hu, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4370-8_3 · Cited by 18
What we can learn from iPSC-derived cellular models of Parkinson's disease
Caiazza, M. C., Lang, C., & Wade‐Martins, R. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.11.002 · Cited by 18
Induced Pluripotent Stem Cells as Vasculature Forming Entities
Palladino, A., Mavaro, I., Pizzoleo, C., Felice, E. D., Lucini, C., de Girolamo, P., Netti, P. A., & Attanasio, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111782 · Cited by 18
Advances in stem-cell–generated transplantation therapy for Parkinson's disease
Sundberg, M., & Isacson, O. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.876986 · Cited by 18
Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) into Osteoclasts
Chen, I. (2020) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3854 · Cited by 18
Racila, D. M., Winter, M. C., Said, M., Tomanek‐Chalkley, A., Wiechert, S., Eckert, R. L., & Bickenbach, J. R. (2010) · Gene Therapy · doi:10.1038/gt.2010.148 · Cited by 18
Activation of pluripotency genes by a nanotube‐mediated protein delivery system
Cho, S. J., Choi, H. W., Cho, J., Jung, S., Seo, H. G., & Tae, J. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22263 · Cited by 18
Induced pluripotent stem cells free of exogenous reprogramming factors
Abujarour, R., & Ding, S. (2009) · Genome biology · doi:10.1186/gb-2009-10-5-220 · Cited by 18
Calafiore, R., & Basta, G. (2015) · Europe PMC (PubMed Central) · Cited by 18
No factor left behind: generation of transgene-free induced pluripotent stem cells.
Li, M., & Belmonte, J. C. I. (2012) · Europe PMC (PubMed Central) · Cited by 18
Cell Sources for Trachea Tissue Engineering: Past, Present and Future
He, X., Fu, W. E., & Zheng, J. (2012) · Regenerative Medicine · doi:10.2217/rme.12.96 · Cited by 18
Gu, H. F., Alvarsson, A., Efendić, S., & Brismar, K. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.11.001 · Cited by 18
Manipulating cell fate through reprogramming: approaches and applications
Yagi, M., Horng, J. E., & Hochedlinger, K. (2024) · Development · doi:10.1242/dev.203090 · Cited by 17
Self-citationHuman Induced Pluripotent Stem Cells: A Review of the US Patent Landscape
Georgieva, B. P., & Love, J. M. (2010) · Regenerative Medicine · doi:10.2217/rme.10.43 · Cited by 17
The challenges and promises of blood engineered from human pluripotent stem cells
Dravid, G. G., & Crooks, G. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.006 · Cited by 17
In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Yılmazer, A., de Lázaro, I., Bussy, C., & Kostarelos, K. (2013) · Journal of Visualized Experiments · doi:10.3791/50837 · Cited by 17
Application of induced pluripotency in cancer studies
Czerwińska, P., Mazurek, S., & Wiznerowicz, M. (2018) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2018.04.005 · Cited by 17
Natural and artificial routes to pluripotency
Krueger, W. H., Swanson, L. C., Tanasijevic, B., & Rasmussen, T. P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103199wk · Cited by 17
Novel cell sources for bone regeneration
Li, C., Mills, Z., & Zheng, Z. S. (2021) · MedComm · doi:10.1002/mco2.51 · Cited by 17
Kaini, R. R., Shen-Gunther, J., Cleland, J. M., Greene, W. A., & Wang, H.-C. H. (2015) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0180 · Cited by 17
Chen, I. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041490 · Cited by 17
Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders
Qin, Y., & Gao, W. (2015) · Stem Cells · doi:10.1002/stem.2112 · Cited by 17
Biomaterials and cells for cardiac tissue engineering
Vu, T. D., & Kofidis, T. (2014) · Elsevier eBooks · doi:10.1533/9780857096715.2.127 · Cited by 17
Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells
Isono, K., Jono, H., Ohya, Y., Shiraki, N., Yamazoe, T., Sugasaki, A., Era, T., Fusaki, N., Tasaki, M., Ueda, M., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.01.004 · Cited by 17
Characterization and Prospective of Human Corneal Endothelial Progenitors
Liu, Y., Sun, H., Guo, P., Hu, M. S., Zhang, Y., Tighe, S. P., Chen, S., & Zhu, Y. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.19018 · Cited by 17
Cellular reprogramming and pluripotency induction
Lensch, M. W. (2009) · British Medical Bulletin · doi:10.1093/bmb/ldp011 · Cited by 17
Szabłowska‐Gadomska, I., Sypecka, J., Zayat, V., Podobińska, M., Pastwińska, A., Pieńkowska‐Grela, B., & Bużańska, L. (2012) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2012-1906 · Cited by 17
Lü, K., Cao, T., & Gordon, R. (2012) · Biosystems · doi:10.1016/j.biosystems.2012.06.001 · Cited by 17
Differentiation roadmap of embryonic Sertoli cells derived from mouse embryonic stem cells
Xu, C., Mohsin, A., Luo, Y., Xie, L., Peng, Y., Wang, Q., Hang, H., Zhuang, Y., & Guo, M. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1180-6 · Cited by 17
Induced pluripotent stem cells and hepatic differentiation
Chiang, C.-H., Huo, T., Sun, C.-C., Hsieh, J.-H., Chien, Y., Lu, K., & Lee, S. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.07.007 · Cited by 16
Zare, A., Salehpour, A., Khoradmehr, A., Bakhshalizadeh, S., Najafzadeh, V., Almasi-turk, S., Mahdipour, M., Shirazi, R., & Tamadon, A. (2023) · Life · doi:10.3390/life13020569 · Cited by 16
Metabolic control of induced pluripotency
Sinenko, S. A., & Tomilin, A. N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1328522 · Cited by 16
Bosnali, M., Münst, B., Thier, M. C., & Edenhofer, F. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0095-2 · Cited by 16
Can controlled cellular reprogramming be achieved using microRNAs?
Sun, X., Fu, X., Han, W., Zhao, Y., & Liu, H. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.06.002 · Cited by 16
Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells
Rami, F., Naderi, S., Mojaver, M., Rahimmanesh, I., Salehi, A. R., & Salehi, R. (2017) · Cellular Reprogramming · doi:10.1089/cell.2016.0034 · Cited by 16
PET molecular imaging in stem cell therapy for neurological diseases
Wang, J., Tian, M., & Zhang, H. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1860-7 · Cited by 16
Reprogramming of Somatic Cells
Rajasingh, J. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00003-4 · Cited by 16
Reprogramming of Mouse Fibroblasts to an Intermediate State of Differentiation by Chemical Induction
Park, J., Kim, C., Tang, Y., Amano, T., Lin, C.-J., & Tian, X. C. (2011) · Cellular Reprogramming · doi:10.1089/cell.2010.0067 · Cited by 16
Stem Cell Based Strategies for Spinal Cord Injury Repair
Reeves, A. L., & Keirstead, H. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4090-1_2 · Cited by 16
Regenerative Medicine and the Gut
Peterson, J., & Pasricha, P. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.010 · Cited by 16
Liu, C. H., Shyu, W., Fu, R., Huang, S.-J., Chang, C., Huang, Y.-C., Chen, S., Lin, S., & Liu, S. (2014) · Cell Transplantation · doi:10.3727/096368914x678391 · Cited by 16
Pera, M. F. (2009) · Nature · doi:10.1038/458715a · Cited by 16
Perspectives on cell reprogramming with RNA
Sul, J., Kim, T. K., Lee, J. H., & Eberwine, J. H. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.02.004 · Cited by 15
Worgall, S., & Crystal, R. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00034-3 · Cited by 15
Somatic Cloning and Epigenetic Reprogramming in Mammals
Niemann, H., Kues, W. A., Lucas‐Hahn, A., & Carnwath, J. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10007-0 · Cited by 15
RNA‐Generated and Gene‐Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy
Kehler, J., Greco, M., Martino, V., Manickam, P., Yokoe, H., Chen, A. P., Yang, M., Auerbach, J., Jessee, J. A., Götte, M., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25597 · Cited by 15
Cellular reprogramming and its application in regenerative medicine
Hong, K. (2014) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-014-0099-3 · Cited by 15
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 15
Bioreactor Systems for Tissue Engineering II
Kasper, C., van Griensven, M., & Pörtner, R. (2010) · Springer eBooks · doi:10.1007/978-3-642-16051-6 · Cited by 15
Kazmerova, Z., Žilka, N., Cente, M., Neradil, P., Žilková, M., & Novák, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130572 · Cited by 15
Swelstad, B. B., & Kerr, C. L. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s8051 · Cited by 15
A virus-free vector for the transfection of somatic cells to obtain IPSC
Varlı, H. S., Alkan, F., Demirbilek, M., & Türkoğlu, N. (2019) · Journal of Nanoparticle Research · doi:10.1007/s11051-019-4668-1 · Cited by 15
Research progress and application prospects of stable porcine pluripotent stem cells
Zhang, J., Zhi, M., Gao, D., Zhu, Q., Gao, J., Zhu, G., Cao, S., & Han, J. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac119 · Cited by 15
Baruselli, P. S., Batista, E. O. S., Vieira, L. M., Sales, J. N. S., Gimenes, L. U., & Ferreira, R. M. (2016) · Animal Reproduction · doi:10.21451/1984-3143-ar907 · Cited by 15
Epigenetics of Embryonic Stem Cells
Calvanese, V., & Fraga, M. F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2098-9_16 · Cited by 15
Research on induced pluripotent stem cells and the application in ocular tissues.
Guo, X., & Chen, J. (2015) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2015.04.31 · Cited by 15
Could co‐transplantation of iPS cells derived hepatocytes and MSCs cure end‐stage liver disease?
Liu, T., Wang, Y., Tai, G., & Zhang, S.-C. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.08.007 · Cited by 15
Mikami, K., & Stephens, N. (2015) · BioSocieties · doi:10.1057/biosoc.2015.35 · Cited by 15
The Use of Animal Models to Study Stem Cell Therapies for Diabetes Mellitus
Song, W., Shah, R., & Hussain, M. A. (2010) · ILAR Journal · doi:10.1093/ilar.51.1.74 · Cited by 14
Jacobs, P. T., Cao, L. H., Samon, J. B., Kane, C. A., Hedblom, E., Bowcock, A. M., & Telfer, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069083 · Cited by 14
Schwartz, R. E., & Verfaillie, C. M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-688-7_9 · Cited by 14
Human Cloning: Four Fallacies and their Legal Consequences
Macintosh, K. L. (2012) · Medical Entomology and Zoology · Cited by 14
Human-Induced Pluripotent Stem Cells in Plastic and Reconstructive Surgery
Hadžimustafić, N., D’Elia, A., Shamoun, V., & Haykal, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031863 · Cited by 14
Studying the pathophysiologic connection between cardiovascular and nervous systems using stem cells
Coskun, V., & Lombardo, D. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23924 · Cited by 14
Current Progress and Potential Practical Application for Human Pluripotent Stem Cells
Philonenko, E. S., Shutova, M. V., Chestkov, I. V., Lagarkova, M. A., & Киселев, С. Л. (2011) · International review of cytology · doi:10.1016/b978-0-12-386033-0.00004-9 · Cited by 14
Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state
Kisby, T., de Lázaro, I., Stylianou, M., Cossu, G., & Kostarelos, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251054 · Cited by 14
Efficient Cell Reprogramming Using Bioengineered Surfaces
Horna, D., Ramírez, J. C., Cifuentes‐Rius, A., Bernad, A., Borrós, S., & González, M. A. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200017 · Cited by 14
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.